# clm_D51C41802591

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 700,100,000 United States dollar  
valid_from: 2020-03-31  
valid_to: 2020-06-30  
published: 2020-05-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C3A6CADA4F04  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly operating income: 700,100,000 United States dollar", as of 2020-03-31 (until 2020-06-30). Claim clm_D51C41802591, https://asof.is/claim/clm_D51C41802591, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422020000011/0001804220-20-000011-index.htm (primary, SEC EDGAR 10-Q Q1 FY2020, published 2020-05-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 738,500,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_D51C41802591](/claim/clm_D51C41802591.md) | [clm_0355C334B021](/claim/clm_0355C334B021.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.